Key statistics
On Tuesday, Catalyst Pharmaceuticals Inc (CPRX:NAQ) closed at 24.27, -8.69% below its 52-week high of 26.58, set on Jun 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 24.53 |
|---|---|
| High | 24.60 |
| Low | 24.03 |
| Bid | 24.00 |
| Offer | 24.50 |
| Previous close | 24.45 |
| Average volume | 1.15m |
|---|---|
| Shares outstanding | 122.91m |
| Free float | 115.36m |
| P/E (TTM) | 14.27 |
| Market cap | 3.01bn USD |
| EPS (TTM) | 1.71 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
Announcements
- Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
- The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
- Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
- Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
- Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
- Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
- Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
- Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
- Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025
More ▼
